PubMed Health⌕ Search

Biomedical subjects

E Gentry

Publications and source records attributed to E Gentry.

4 recordsLinked to original sources
PubMed1990

A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD.

Thirty-two patients presenting with acute exacerbations of chronic obstructive pulmonary disease were entered into the following double-blind, crossover study. First (time 0), patients inhaled either ipratropium bromide (54 micrograms) or metaproterenol sulfate (1.95 mg) via a metered dose inhaler (MDI) attached to a device (Inspirease) (phase 1). After 90 minutes, they inhaled whichever of the two medications they had not received in phase 1. This is referred to as phase 2. Pulmonary function (FEV1 and FVC) was measured at time 0, and at 30, 60, and 90 minutes following phase 1 treatment, and at 30, 60, and 90 minutes following phase 2 treatment (120, 150, and 180 minutes from the start of the study). Arterial blood gas samples (n = 20) were obtained at entry into the study and 30 and 90 minutes after phase 1 medication. The groups did not differ in age, degree of airway obstruction, hypoxemia, or theophylline usage at the start of the study. In phase 1, at 90 minutes, pulmonary function in both groups significantly and similarly improved. For ipratropium, FEV1 improved from 0.62 +/- 0.08 L to 0.88 +/- 0.11 L (p less than 0.01) and for metaproterenol FEV1 improved from 0.69 +/- 0.06 to 0.92 +/- 0.09 L (p less than 0.01). There was no further improvement with phase 2 treatment for either group. Thirty minutes after inhaling ipratropium, there was a small but significant rise in PO2 (5.8 +/- 3.0 mm Hg; p less than 0.05) while metaproterenol inhalation resulted in a 6.2 +/- 1.2 mm Hg decline in PO2 (p less than 0.05). These changes were not sustained at 90 minutes. We concluded that for acute exacerbations of COPD, both ipratropium and metaproterenol are effective medications when administered via an MDI attached to a device (Inspirease). However, ipratropium may be a safer choice as it initially did not cause a decline in blood oxygenation.

Acute Disease↗
PubMed1983

Morphological alterations in dura mater encephali used as ventricular wall grafts in the canine heart.

Structural changes within homologous dura mater patch-grafts surgically implanted in the right ventricular wall of the heart were studied in nine adult dogs utilizing light microscopy and transmission and scanning electron microscopy. Physical examination of the dogs after surgery presented no clinical signs of abnormalities caused by either the surgery or the nature of the graft. After one week of implantation, a fibrous organization extending from the wound margins over the entire graft greatly increased its thickness. In addition, it was observed that (1) an increase in cellularity, vascularity and connective tissue elements occurred on the external surface of the patch-graft, (2) these same changes occurred regardless of which surface (periosteal or arachnoidal) was used as the external or pericardial surface, (3) the graft core underwent a transition from a relatively acellular and avascular connective tissue structure into one that was heavily infiltrated by a variety of cellular elements and new blood vessels, and (4) these morphological changes were interpreted as an attempt to incorporate the graft into the host tissue, resulting in an increase in both viability and stability of the graft. These findings indicate that homologous dura mater is a suitable material for use in the surgical repair of the cardiac wall.

Animals↗
PubMed1983

Study of the periosteal and arachnoidal aspects of dura mater implanted surgically in the ventricular wall of the canine heart.

After surgical removal of a portion of the cardiac wall, homologous dura mater cardiac grafts were sutured to the margins of the incision in the sternocostal wall of the right ventricle of the canine heart and recovered after 1, 4, 6 and 8 weeks of implantation. Representative tissue specimens were processed for and studied by means of SEM and TEM. The primary objectives were to study morphological changes in the dura mater grafts used to repair the lesions or defects in the cardiac wall and to compare alterations in the periosteal and arachnoidal aspects of the dura mater grafts after being implanted for varying periods of time. After one week of implantation, an amorphous layer of fibrin was deposited on or near the luminal surface of the original dura mater grafts. At four weeks of grafts implantation, a 'remodeling' process was apparent below the luminal surface of the graft. Although a large accumulation of fibrin was still present at this time, there was also an increase in the number of cellular and fibrillar components within the implant. Large numbers of macrophages and active fibroblasts were visible at this time along with new collagen. At the sixth week of implantation, an abundance of active fibroblasts, the presence of normal collagen and a darkly staining material interpreted as recently synthesized connective tissue components, fibrin deposits and/or degenerating collagen were also observed. Phagocytosis of the remaining fibrin was noted during this period indicating a continuation of the remodeling process at the luminal surface. Finally, after eight weeks of implantation, it was revealed that the original densely woven and relatively acellular graft had become infiltrated with various blood cells and vascular channels.

Animals↗